Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Provectus Biopharmaceuticals Inc PVCT

Healthcare
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform... see more

Recent & Breaking News (OTCQB:PVCT)

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT

Marketwired July 25, 2014

Leading Health Care Stock for Small-Cap Stars is Organovo (ONVO) for July 24

Equities.com July 24, 2014

Datawatch Corporation (DWCH) Leads Small-Cap Stars in Early Trading for July 24

Equities.com July 24, 2014

Overstock.com Inc. (OSTK) Leads Small-Cap Stars in Early Trading for July 24

Equities.com July 24, 2014

Provectus Biopharmaceuticals' PV-10 Clinical Data on the Treatment of Melanoma to Be Presented at European Society for Medical Oncology 2014 Congress

Business Wire July 23, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 in Provectus Biopharmaceuticals, Inc. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- PVCT

GlobeNewswire July 22, 2014

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc.

Business Wire July 15, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Provectus Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PVCT

GlobeNewswire July 14, 2014

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc.

Business Wire July 8, 2014

Provectus Updates Shareholders in Its Annual CEO Letter

Business Wire July 8, 2014

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess Of $100,000 Investing in Provectus Biopharmaceuticals, Inc. to Contact the Firm -- PVCT

GlobeNewswire July 4, 2014

SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Reminds Investors of Provectus Biopharmaceuticals, Inc. of Upcoming July 28, 2014 Deadline

Business Wire July 3, 2014

EQUITY ALERT: The Rosen Law Firm Reminds Provectus Biopharmaceuticals, Inc. Investors of Important Class Action Deadline - PVCT

GlobeNewswire July 1, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT

PR Newswire June 27, 2014

INVESTOR ALERT: Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. Announced by Glancy Binkow & Goldberg LLP

Business Wire June 26, 2014

Provectus Biopharmaceuticals, Inc. to Hold Conference Call Today to Detail Outline of Phase 3 Clinical Trial of PV-10 in Melanoma Treatment

Business Wire June 19, 2014

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Provectus Biopharmaceuticals, Inc.

Business Wire June 18, 2014

INVESTOR ALERT: Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith

Business Wire June 17, 2014

Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Provectus Biopharmaceuticals, Inc. (PVCT) and Announces Investigations into Aegerion Pharmaceuticals (AEGR), Aeroflex Holding (ARX), Annie's (BNNY), Altisource Residential (RESI), Fusion-io (FIO), Hertz Global Holdings (HTZ), Hittite Microwave (HITT), Medifast (MED), PetroLogistics (PDH), Ply Gem Holdings (PGEM), Protective Life (PL), Regional Management (RM), Ruby Tuesday, Inc. (RT), tw te

PR Newswire June 16, 2014

Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Provectus Biopharmaceuticals, Inc., and The Bancorp Inc.

PR Newswire June 14, 2014